Notes / Company

Beryl Drugs Ltd.

BERLDRG BSE 524606 ISIN INE415H01017 Pharmaceuticals

Fundamentals

Market cap: ₹11.92 cr
P/E: 28.04×
ROE: 6.09%
Debt / equity: 0.43
52-week range: 15.92 — 30.00

Research on Tijori Finance

Company snapshot

Beryl Drugs Ltd.

Pharmaceuticals

₹11 cr

P/E 25.32×

Latest quarter · Mar 2026

Sales₹5 cr

Net profit₹1 cr

Op. margin+24.5%

EPS₹1.11

Strength & growth

Debt / equity0.43×

Current ratio2.08×

Sales CAGR+3.7%

EPS CAGR+7.9%

The timeline — 1 note on Beryl Drugs Ltd.

June 2026

29 Jun 26 · 1:04 PM IST Lead

Lead · M&A · Micro cap

Beryl Drugs promoter crosses 10% with small open-market buy

Sudhir Sethi picked up 6,950 shares, lifting his stake from 9.915% to 10.055%. The ₹12 cr nano-cap sees a modest signal of promoter confidence.

Verify on exchange BSE filings for BERLDRG NSE filings for BERLDRG Tijori Finance company page